Plain-English translation of NCT04538859 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at Chinese University of Hong Kong are studying adults with bronchiectasis — a condition where parts of the lungs are permanently damaged and inflamed — to understand which patients are most at risk for serious flare-ups and complications. The study will collect information from about 400 patients to identify patterns and factors that predict when the disease will worsen. This research aims to help doctors predict problems earlier and improve treatment plans.
Bronchiectasis causes repeated flare-ups that send many patients to the hospital and reduce quality of life. An earlier study showed this is a significant problem in Hong Kong, but that data is now over 10 years old. Doctors need updated information to better understand who is at highest risk and how to prevent serious complications.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow researchers to access your medical information and track your health over time to see how your bronchiectasis progresses. You would likely have clinic visits where doctors monitor your symptoms, flare-ups, and overall lung function. The study does not involve taking a new medication — instead, it focuses on gathering information from your existing medical care to help identify patterns and predictors of disease severity.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
Hong Kong
Sponsor
Chinese University of Hong Kong
Enrollment target
~400 participants
Started
August 2020
Primary completion
August 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2020.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.